Login
| TI Ref No : | 517405777 |
|---|---|
| Description : | Tenders Are Invited For Ex-ante Transparency Announcement Section 130a (8) Sgb V Lytenava (r) Active Ingredient: Bevacizumab Gamma Atc Code: S01la08.ex-ante Transparency Announcement Section 130a (8) Sgb V Lytenava (r) Active Ingredient: Bevacizumab Gamma |
| Date : | 2025-04-29 |
| Deadline : | 2025-07-29 |
| Document Type : | Contracts |
